Abstract:Qingcheng Song, 1, 2, &ast Yiran Zhang, 3, &ast Hongzhi Hu, 4, &ast Xuemei Yang, 5 Xin Xing, 1, 2 Jianhua Wu, 6 Yanbin Zhu, 1, 2 Yingze Zhang 1, 2 1 Department of Orthopaedic Surgery, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 2 Orthopaedic Institution of Hebei Province, Shijiazhuang, Hebei, People's Republic of China; 3 School of Medicine, Nankai University, Tianjin, People's Republic of China; 4 Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China; 5 The Fourth Hospital of Shijiazhuang, Shijiazhuang, Hebei, People's Republic of China; 6 The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yingze Zhang; Yanbin Zhu, Email ; Introduction: Ferroptosis-driven tumor ablation strategies based on nanotechnology could be achieved by elevating intracellular iron levels or inhibiting glutathione peroxidase 4 (GPX4) activity. However, the intracellular antioxidative defense mechanisms endow tumor cells with ferroptosis resistance capacity. The purpose of this study was to develop a synergistic therapeutic platform to enhance the efficacy of ferroptosis-based tumor therapy. Methods: In this study, a multifunctional nano-catalytic therapeutic platform (mFeB@PDA-FA) based on chemodynamic therapy (CDT) and photothermal therapy (PTT) was developed to effectively trigger ferroptosis in tumor. In our work, iron-based mesoporous Fe 3 O 4 nanoparticles (mFe 3 O 4 NPs) were employed for the encapsulation of L-buthionine sulfoximine (BSO), followed by the modification of folic acid-functionalized polydopamine (PDA) coating on the periphery. Then, the antitumor effect of mFeB@PDA-FA NPs was evaluated using Human OS cells (MNNG/HOS) and a subcutaneous xenograft model of osteosarcoma. Results: mFe 3 O 4 harboring multivalent elements (Fe 2+/3+ ) could catalyze hydrogen peroxide (H 2 O 2 ) into highly cytotoxic &dotOH, while the tumor microenvironment (TME)-responsive released BSO molecules inhibit the biosynthesis of GSH, thus achieving the deactivation of GPX4 and the enhancement of ferroptosis. Moreover, thanks to the remarkable photothermal conversion performance of mFe 3 O 4 and PDA shell, PTT further synergistically enhanced the efficacy of CDT and facilitated ferroptosis. Both in vivo and in vitro experiments confirmed that this synergistic therapy could achieve excellent tumor inhibition effects. Conclusion: The nanotherapeutic platform mFeB@PDA-FA could effectively disrupted the redox homeostasis in tumor cells for boosting ferroptosis through the combination of CDT, PTT and GSH elimination, which provided a new perspective for the treatment of ferroptosis sensitive tumors. Keywords: ferroptosis, chemodynamic therapy, photothermal therapy, Fenton reaction, BSO Graphical Osteosarcoma (OS) is the most common primary malignant bone tumor and the leading cause of cancer-related death in children and adolescents. 1,2 At present, the common treatment methods of OS are surgical resection, systemic chemotherapy and radiotherapy, but the therapeutic approaches are far from satisfactory due to chemotherapy resistance and postoperative distant metastasis. 3–5 Hence, the development of new strategies that combine biomedicine with emerging nanotechnology to find alternative ways to stimulate cell death may overcome the current therapeutic dilemma. 6 Ferroptosis, as a non-apoptotic form of programmed cell death, has received considerable attention due to its unique properties associated with various diseases, including cancer. 7,8 Different from traditional apoptosis and necrosis, ferroptosis is mainly characterized by iron-dependent ROS generation and lipid peroxidation (LPO), which is of great significance for killing tumor cells resistant to necrosis and apoptosis. 9,10 Therefore, the intracellular redox active iron (Fe 2+ ) level is the key elements in the process of inducing ferroptosis, which could catalyze the decomposition of hydrogen peroxide (H 2 O 2 ) in the tumor microenvironment (TME) to generate highly toxic hydroxyl radicals ( ̇OH) based on Fenton reaction and promote the accumulation of lipid peroxides, thus causing damage to the structure and inte -Abstract Truncated-

Reactive Oxygen-Primed and Autophagy Inhibition-Sensitized Ferroptosis Combined with Photothermal Ablation for Tumor Therapy

Targeted Gsh-Exhausting And Hydroxyl Radical Self-Producing Manganese-Silica Nanomissiles For Mri Guided Ferroptotic Cancer Therapy

Photothermal-Enhanced Inactivation of Glutathione Peroxidase for Ferroptosis Sensitized by an Autophagy Promotor

Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy

Photothermal Nanozymatic Nanoparticles Induce Ferroptosis and Apoptosis Through Tumor Microenvironment Manipulation for Cancer Therapy

Activatable Plasmonic Versatile Nanoplatform for Glutathione-Depletion Augmented Ferroptosis and NIR-II Photothermal Synergistic Therapy

Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy

A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and Immunotherapy

Topology-regulated Nanocatalysts for Ferroptosis-Mediated Cancer Phototherapy.

Augment of Ferroptosis with Photothermal Enhanced Fenton Reaction and Glutathione Inhibition for Tumor Synergistic Nano-Catalytic Therapy

Enhanced ferroptosis therapy with a "nano-destructor" by disrupting intracellular redox and iron homeostasis

Lactic Acid Responsive Sequential Production of Hydrogen Peroxide and Consumption of Glutathione for Enhanced Ferroptosis Tumor Therapy

Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy

A pH-sensitive imidazole grafted polymeric micelles nanoplatform based on ROS amplification for ferroptosis-enhanced chemodynamic therapy

Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy

Multi-responsive cascade enzyme-like catalytic nanoassembly for ferroptosis amplification and nanozyme-assisted mild photothermal therapy

A Fe(III)-porphyrin-oxaliplatin(IV) Nanoplatform for Enhanced Ferroptosis and Combined Therapy

Multifunctional Platinum Doped Porous FeS 2 Nanoparticles for Photothermal Enhanced Photodynamic Ferroptosis Combination Therapy

Engineering dual catalytic nanomedicine for autophagy-augmented and ferroptosis-involved cancer nanotherapy

Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.

A strategy of "adding fuel to the flames" enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy